Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.62 |
| ▸ | LMNA | P02545 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.62 |
| ▸ | NEU1 | Q99519 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13448858 | 1.00 | MEN1 (0.62) | MEN1LMNACYP3A4KMT2ANEU1 | |
| SCHEMBL28738706 | 1.00 | MEN1 (0.62) | MEN1LMNACYP3A4KMT2ANEU1 | |
| SCHEMBL22410774 | 1.00 | MEN1 (0.62) | MEN1LMNACYP3A4KMT2ANEU1 | |
| SCHEMBL15933160 | 0.92 | MEN1 (0.52) | MEN1LMNACYP3A4KMT2A | |
| SCHEMBL15933158 | 0.89 | — | — | |
| SCHEMBL30513880 | 0.87 | MEN1 (0.46) | MEN1LMNACYP3A4KMT2ANEU1 | |
| SCHEMBL30513885 | 0.87 | MEN1 (0.46) | MEN1LMNACYP3A4KMT2ANEU1 | |
| SCHEMBL13839338 | 0.85 | MEN1 (0.48) | MEN1LMNACYP3A4KMT2ANEU1 | |
| SCHEMBL13448885 | 0.84 | — | — | |
| SCHEMBL15481366 | 0.84 | MEN1 (0.47) | MEN1LMNACYP3A4KMT2ANEU1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2190439-B1 | OSELTAMIVIR PHOSPHONATE DERIVATIVES WITH ANTI-INFLUENZA ACTIVITY AND SYNTHESIS THEREOF | ACADEMIA SINICA (TW) | 2016-03-09 | — | — | EP | disclosed |
| US-7888337-B2 | Synthesis of oseltamivir containing phosphonate congeners with anti-influenza activity | ACADEMIA SINICA (TW) | 2011-02-15 | — | — | US | disclosed |
| US-20100113397-A1 | SYNTHESIS OF OSELTAMIVIR CONTAINING PHOSPHONATE CONGENERS WITH ANTI-INFLUENZA ACTIVITY | ACADEMIA SINICA (TW) | 2010-05-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100113397-A1 | SYNTHESIS OF OSELTAMIVIR CONTAINING PHOSPHONATE CONGENERS WITH ANTI-INFLUENZA ACTIVITY | TALDO1, DUSP4, PNP | MEN1 2801/4885LMNA 3902/4885CYP3A4 365/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.